NIH-funded research R01 grant

Investigating how a protein affects sodium reabsorption and high blood pressure

Official title: Novel Role Of ACTN4 in Sodium Reabsorption and Salt-Sensitive Hypertension

Funded at Beth Israel Deaconess Medical Center · NIH-11000324 · Data updated 2026-11-12

This study is looking at how a protein called ACTN4 affects the way your kidneys handle salt and blood pressure, especially for people who are sensitive to salt, to help find new ways to treat high blood pressure.

More Hypertension research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startDecember 15, 2023
Project endNovember 30, 2027
Funding year2025
Award (this year)$631,041
NIH project number5R01HL171121-02
Project IDNIH-11000324 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with salt-sensitive hypertension or those at risk for developing high blood pressure.

Less likely to help

Patients with hypertension not related to sodium reabsorption or those with other underlying causes of high blood pressure may not benefit from this research.

What this research studies

This research focuses on understanding the role of a protein called ACTN4 in sodium reabsorption and its connection to salt-sensitive hypertension. Using advanced organ-on-chip technology, researchers will study how mutations in ACTN4 influence sodium handling in kidney cells. The study aims to determine how these mutations affect blood pressure regulation by altering the activity of sodium transporters in the kidneys. By examining these mechanisms, the research seeks to provide insights into potential new treatments for hypertension.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for managing salt-sensitive hypertension in patients.

How similar studies have gone: Previous research has shown promising results in understanding sodium transport mechanisms, but this specific approach using ACTN4 is relatively novel.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Feng, Di — Beth Israel Deaconess Medical Center
  • Study coordinator: Feng, Di

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.